JP2012525323A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525323A5
JP2012525323A5 JP2011545129A JP2011545129A JP2012525323A5 JP 2012525323 A5 JP2012525323 A5 JP 2012525323A5 JP 2011545129 A JP2011545129 A JP 2011545129A JP 2011545129 A JP2011545129 A JP 2011545129A JP 2012525323 A5 JP2012525323 A5 JP 2012525323A5
Authority
JP
Japan
Prior art keywords
salt
solid preparation
biphenyl
ethoxy
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011545129A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012525323A (ja
JP5666471B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011545129A priority Critical patent/JP5666471B2/ja
Priority claimed from JP2011545129A external-priority patent/JP5666471B2/ja
Publication of JP2012525323A publication Critical patent/JP2012525323A/ja
Publication of JP2012525323A5 publication Critical patent/JP2012525323A5/ja
Application granted granted Critical
Publication of JP5666471B2 publication Critical patent/JP5666471B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011545129A 2009-04-30 2010-04-28 固形製剤 Active JP5666471B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011545129A JP5666471B2 (ja) 2009-04-30 2010-04-28 固形製剤

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2009111381 2009-04-30
JP2009111381 2009-04-30
JP2010068625 2010-03-24
JP2010068625 2010-03-24
JP2011545129A JP5666471B2 (ja) 2009-04-30 2010-04-28 固形製剤
PCT/JP2010/057923 WO2010126168A2 (en) 2009-04-30 2010-04-28 Solid preparation

Publications (3)

Publication Number Publication Date
JP2012525323A JP2012525323A (ja) 2012-10-22
JP2012525323A5 true JP2012525323A5 (cg-RX-API-DMAC7.html) 2013-06-06
JP5666471B2 JP5666471B2 (ja) 2015-02-12

Family

ID=43032637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011545129A Active JP5666471B2 (ja) 2009-04-30 2010-04-28 固形製剤

Country Status (24)

Country Link
EP (1) EP2424501A2 (cg-RX-API-DMAC7.html)
JP (1) JP5666471B2 (cg-RX-API-DMAC7.html)
KR (1) KR101797776B1 (cg-RX-API-DMAC7.html)
CN (1) CN102481248B (cg-RX-API-DMAC7.html)
AU (1) AU2010242308A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1014388A2 (cg-RX-API-DMAC7.html)
CA (1) CA2760073A1 (cg-RX-API-DMAC7.html)
CL (1) CL2011002662A1 (cg-RX-API-DMAC7.html)
CO (1) CO6470841A2 (cg-RX-API-DMAC7.html)
CR (1) CR20110581A (cg-RX-API-DMAC7.html)
DO (1) DOP2011000329A (cg-RX-API-DMAC7.html)
EA (1) EA201171329A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP11011494A (cg-RX-API-DMAC7.html)
GE (1) GEP20135940B (cg-RX-API-DMAC7.html)
IL (1) IL215962A0 (cg-RX-API-DMAC7.html)
MA (1) MA33280B1 (cg-RX-API-DMAC7.html)
MX (1) MX2011011011A (cg-RX-API-DMAC7.html)
MY (1) MY158158A (cg-RX-API-DMAC7.html)
NZ (1) NZ596395A (cg-RX-API-DMAC7.html)
PE (1) PE20120315A1 (cg-RX-API-DMAC7.html)
SG (1) SG175794A1 (cg-RX-API-DMAC7.html)
TW (1) TWI438201B (cg-RX-API-DMAC7.html)
WO (1) WO2010126168A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201108375B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL236001B1 (pl) 2012-12-21 2020-11-30 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
KR101535586B1 (ko) * 2014-08-01 2015-07-09 에스케이케미칼주식회사 무정형 또는 열역학적 준 안정형 리바록사반을 포함하는 약학 제제
WO2016122256A1 (ko) * 2015-01-30 2016-08-04 씨제이헬스케어 주식회사 칸데사르탄 및 암로디핀을 포함하는 약제학적 조성물
CN106668016B (zh) * 2015-11-11 2020-06-23 江苏先声药业有限公司 阿齐沙坦和苯磺酸氨氯地平组合物的固体制剂及其制备方法
JP2017210435A (ja) * 2016-05-25 2017-11-30 ダイト株式会社 イルベサルタン及びアムロジピンベシル酸塩配合錠の製造方法
JP2019001782A (ja) * 2017-06-14 2019-01-10 東和薬品株式会社 二層錠
JP7101464B2 (ja) * 2017-09-28 2022-07-15 エルメッド株式会社 アジルサルタン又はその塩及びアムロジピン又はその塩含有錠剤の品質向上方法、並びにアジルサルタン又はその塩及びアムロジピン又はその塩含有錠剤及びその製造方法
CN108210472A (zh) * 2017-12-15 2018-06-29 蚌埠丰原医药科技发展有限公司 一种西尼地平固体分散体片剂及其制备方法
CN108685925B (zh) * 2018-05-15 2019-12-06 徐州医科大学 一种化合物AB-38b在制备治疗糖尿病肾病药物方面的应用
JP2020075869A (ja) * 2018-11-05 2020-05-21 日本ケミファ株式会社 カルシウム拮抗剤及びアンジオテンシンii受容体拮抗剤を有効成分として含有する錠剤
JP2020090471A (ja) * 2018-12-07 2020-06-11 ニプロ株式会社 アジルサルタン及びアムロジピンを含有する医薬組成物及びその製造方法
JP7206872B2 (ja) * 2018-12-07 2023-01-18 ニプロ株式会社 アジルサルタン及びアムロジピンを含有する医薬組成物及びその製造方法
JP7441105B2 (ja) * 2020-03-31 2024-02-29 日本ジェネリック株式会社 アジルサルタン及びアムロジピンベシル酸塩を含有するフィルムコーティング錠

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2814513B2 (ja) * 1988-02-03 1998-10-22 吉富製薬株式会社 溶出性の改良された製剤組成物
CA2125251C (en) * 1993-06-07 2005-04-26 Yoshiyuki Inada A pharmaceutical composition for angiotensin ii-mediated diseases
JP3057471B2 (ja) * 1993-06-07 2000-06-26 武田薬品工業株式会社 アンジオテンシンii介在性諸疾患の予防または治療剤
US20030187023A1 (en) 2000-07-17 2003-10-02 Keiji Kubo Sulfone derivatives, process for their production and use thereof
EP1369130A1 (en) * 2001-03-16 2003-12-10 Takeda Chemical Industries, Ltd. Process for producing sustained release preparation
US20050032854A1 (en) * 2001-12-03 2005-02-10 Kiminori Kawahara Insulin resistance improving agents
AU2003235395A1 (en) * 2002-05-22 2003-12-02 Shionogi And Co., Ltd. Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
WO2004048363A1 (ja) 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
WO2005030740A1 (ja) 2003-09-30 2005-04-07 Takeda Pharmaceutical Company Limited チアゾリン誘導体およびその用途
JP4769082B2 (ja) 2003-12-17 2011-09-07 武田薬品工業株式会社 ウレア誘導体、その製造法及び用途
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
JP2006321726A (ja) * 2005-05-17 2006-11-30 Sysmex Corp 錠剤の溶出性調整方法
TWI407978B (zh) * 2005-06-27 2013-09-11 Sankyo Co 濕粒狀藥物之製備方法
CN101247832B (zh) * 2005-06-27 2011-12-28 第一三共株式会社 含有血管紧张素ⅱ受体拮抗剂和钙通道阻断剂的药物制剂
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
CN101652139A (zh) * 2007-03-29 2010-02-17 第一三共株式会社 药物组合物
TW201014850A (en) * 2008-09-25 2010-04-16 Takeda Pharmaceutical Solid pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2012525323A5 (cg-RX-API-DMAC7.html)
NZ596395A (en) Stable solid benzimidazole derivative preparation having optimized dissolution property
CA2514921A1 (en) Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension
CA2613417A1 (en) Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
HRP20160987T1 (hr) Farmaceutski oblik doziranja koji sadrži nifedipin ili nisoldipin i antagonist angiotenzina-ii i/ili diuretik
TWI246921B (en) Stabilized pharmaceutical composition with calcium blocker
ES3038007T3 (en) Combinations of aprocitentan with further active ingredients for the treatment of resistant hypertension
JP2014531461A5 (cg-RX-API-DMAC7.html)
JP2010507602A5 (cg-RX-API-DMAC7.html)
JP2010265321A5 (cg-RX-API-DMAC7.html)
JP2017523972A5 (cg-RX-API-DMAC7.html)
JP2020506180A5 (cg-RX-API-DMAC7.html)
JP2012533546A5 (cg-RX-API-DMAC7.html)
AR068947A1 (es) Inhibidor de la proteina activadora de la 5- lipoxigenasa (flap), composiciones farmaceuticas, sales y solvatos
HRP20090593T1 (hr) Derivati benzimidazola i njihova uporaba kao antagonista aii receptora
RU2019126749A (ru) Композиции для лечения гипертензии
JP2010513322A5 (cg-RX-API-DMAC7.html)
US20090221656A1 (en) Drug Combinations
PE20110844A1 (es) Composicion farmaceutica solida
JP2014532754A5 (cg-RX-API-DMAC7.html)
JP2013501729A5 (cg-RX-API-DMAC7.html)
RU2014141046A (ru) Амидопиридиновое производное и его применение
JP6532984B2 (ja) 高血圧症の予防又は治療のための併用医薬
CA2436361A1 (en) Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
JP2011518843A5 (cg-RX-API-DMAC7.html)